ZOLEDRONAT Fresenius Onco 4 mg/5ml flac 5 ml

7680624810013 CH-62481 M05BA08 07.99.0.
ZOLEDRONAT Fresenius Onco 4 mg/5ml flac 5 ml
ZOLEDRONAT Fresenius Onco 4 mg/5ml flac 5 ml
ZOLEDRONAT Fresenius Onco 4 mg/5ml flac 5 ml
1 / 3
google

Details

Product number
6248101
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
acidum zoledronicum 4 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 5.65 mg.

Articles (1)

Zoledronat Fresenius Onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
05/11/2024
Professional SmPC
Français
05/11/2024
Professional SmPC
Italien
05/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
5.65 MG Substance HBESI

Reimbursement information

Public price
CHF 124.00
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2013

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
62481
Drug name
Zoledronat Fresenius Onco, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
M05BA08
Authorization status
Z
Dispensation category
B
First authorization
28/09/2012
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumoren und multiples Myelom, maligne Hypercalcämie

Packaging details

Description (FR)
ZOLEDRONAT Fresenius Onco 4 mg/5ml flac 5 ml
Description (DE)
ZOLEDRONAT Fresenius Onco 4 mg/5ml Durchstf 5 ml
Market launch
28/09/2012
Narcotic (BTM)
No

Original drug

Aclasta, Infusionslösung
CHF 254.45
View original

Other packaging sizes